Experience with liposomal amphotericin B in outpatient parenteral antimicrobial therapy

Keyphrases

• Actual Weight 10%
• Acute Kidney Injury 20%
• Adverse Events 40%
• Age 50 10%
• Am(III) 10%
• Antimicrobial 10%
• At Discharge 10%
• Close Monitoring 10%
• Histoplasmosis 10%
• Hypokalemia 10%
• Liposomal Amphotericin B 100%
• Long-term Sequelae 10%
• Low Serum 10%
• Median Time 10%
• Outpatient Parenteral Antibiotic Therapy 100%
• Outpatient Setting 20%
• Patient Demographics 10%
• Patient-completed 10%
• Potassium Supplementation 10%
• Readmission 20%
• Renal Recovery 10%
• Serum Potassium 10%
• Therapy Initiation 10%
• Treatment Strategy 10%
• Ultra-low Dose 10%
• Worse Outcome 10%

Medicine and Dentistry

• Acute Kidney Injury 20%
• Adverse Event 40%
• Amphotericin B 100%
• Antimicrobial Therapy 100%
• Body Weight 10%
• Histoplasmosis 10%
• Hypokalemia 10%
• Low Drug Dose 10%
• Outpatient 100%
• Patient Population 10%
• Sequela 10%
• Supplementation 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Kidney Failure 20%
• Adverse Event 40%
• Amphotericin B 100%
• Antimicrobial Therapy 100%
• Histoplasmosis 10%
• Hypokalemia 10%
• Isotopes of Potassium 20%